159 related articles for article (PubMed ID: 10381487)
1. Anti-inflammatory effects of systemic anti-tumour necrosis factor alpha treatment in human/murine SCID arthritis.
Schädlich H; Ermann J; Biskop M; Falk W; Sperling F; Jüngel A; Lehmann J; Emmrich F; Sack U
Ann Rheum Dis; 1999 Jul; 58(7):428-34. PubMed ID: 10381487
[TBL] [Abstract][Full Text] [Related]
2. Effects of treatment with a fully human anti-tumour necrosis factor alpha monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNFalpha in patients with rheumatoid arthritis.
Barrera P; Joosten LA; den Broeder AA; van de Putte LB; van Riel PL; van den Berg WB
Ann Rheum Dis; 2001 Jul; 60(7):660-9. PubMed ID: 11406520
[TBL] [Abstract][Full Text] [Related]
3. Systemic characteristics of chronic arthritis induced by transfer of human rheumatoid synovial membrane into SCID mice (human/murine SCID arthritis).
Sack U; Günther A; Pfeiffer R; Genest M; Kinne J; Biskop M; Kämpfer I; Krenn V; Emmrich F; Lehmann J
J Autoimmun; 1999 Nov; 13(3):335-46. PubMed ID: 10550221
[TBL] [Abstract][Full Text] [Related]
4. The role of TNF-alpha in the pathogenesis of inflammation and joint destruction in rheumatoid arthritis (RA): a study using a human RA/SCID mouse chimera.
Matsuno H; Yudoh K; Katayama R; Nakazawa F; Uzuki M; Sawai T; Yonezawa T; Saeki Y; Panayi GS; Pitzalis C; Kimura T
Rheumatology (Oxford); 2002 Mar; 41(3):329-37. PubMed ID: 11934972
[TBL] [Abstract][Full Text] [Related]
5. Treatment of rheumatoid synovitis with anti-reshaping human interleukin-6 receptor monoclonal antibody: use of rheumatoid arthritis tissue implants in the SCID mouse model.
Matsuno H; Sawai T; Nezuka T; Uzuki M; Tsuji H; Nishimoto N; Yoshizaki K
Arthritis Rheum; 1998 Nov; 41(11):2014-21. PubMed ID: 9811057
[TBL] [Abstract][Full Text] [Related]
6. Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis.
Taylor PC; Peters AM; Paleolog E; Chapman PT; Elliott MJ; McCloskey R; Feldmann M; Maini RN
Arthritis Rheum; 2000 Jan; 43(1):38-47. PubMed ID: 10643698
[TBL] [Abstract][Full Text] [Related]
7. Grafting of fibroblasts isolated from the synovial membrane of rheumatoid arthritis (RA) patients induces chronic arthritis in SCID mice-A novel model for studying the arthritogenic role of RA fibroblasts in vivo.
Lehmann J; Jüngel A; Lehmann I; Busse F; Biskop M; Saalbach A; Emmrich F; Sack U
J Autoimmun; 2000 Nov; 15(3):301-13. PubMed ID: 11040071
[TBL] [Abstract][Full Text] [Related]
8. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
[TBL] [Abstract][Full Text] [Related]
9. What is the mechanism of action of anti-tumour necrosis factor-alpha antibody in rheumatoid arthritis?
Feldmann M
Int Arch Allergy Immunol; 1996 Dec; 111(4):362-5. PubMed ID: 8957109
[TBL] [Abstract][Full Text] [Related]
10. Characterization of pristane-induced arthritis, a murine model of chronic disease: response to antirheumatic agents, expression of joint cytokines, and immunopathology.
Patten C; Bush K; Rioja I; Morgan R; Wooley P; Trill J; Life P
Arthritis Rheum; 2004 Oct; 50(10):3334-45. PubMed ID: 15476226
[TBL] [Abstract][Full Text] [Related]
11. Orthotopic implantation of inflamed synovial tissue from RA patients induces a characteristic arthritis in immunodeficient (SCID) mice.
Sack U; Kuhn H; Kämpfer I; Genest M; Arnold S; Pfeiffer G; Emmrich F
J Autoimmun; 1996 Feb; 9(1):51-8. PubMed ID: 8845054
[TBL] [Abstract][Full Text] [Related]
12. Persistence of interleukin 7 activity and levels on tumour necrosis factor alpha blockade in patients with rheumatoid arthritis.
van Roon JA; Hartgring SA; Wenting-van Wijk M; Jacobs KM; Tak PP; Bijlsma JW; Lafeber FP
Ann Rheum Dis; 2007 May; 66(5):664-9. PubMed ID: 17185327
[TBL] [Abstract][Full Text] [Related]
13. Transcription factor snail regulates tumor necrosis factor α-mediated synovial fibroblast activation in the rheumatoid joint.
Chen SY; Shiau AL; Li YT; Lin CC; Jou IM; Liu MF; Wu CL; Wang CR
Arthritis Rheumatol; 2015 Jan; 67(1):39-50. PubMed ID: 25303734
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of CD147/HAb18 monoclonal antibody on cartilage erosion and synovitis in the SCID mouse model for rheumatoid arthritis.
Jia J; Wang C; Shi Z; Zhao J; Jia Y; Zhao-Hui Z; Li X; Chen Z; Zhu P
Rheumatology (Oxford); 2009 Jul; 48(7):721-6. PubMed ID: 19429906
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.
Williams RO; Feldmann M; Maini RN
Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9784-8. PubMed ID: 1409699
[TBL] [Abstract][Full Text] [Related]
16. Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.
Nakahara H; Song J; Sugimoto M; Hagihara K; Kishimoto T; Yoshizaki K; Nishimoto N
Arthritis Rheum; 2003 Jun; 48(6):1521-9. PubMed ID: 12794819
[TBL] [Abstract][Full Text] [Related]
17. Activation of cannabinoid receptor 2 attenuates synovitis and joint distruction in collagen-induced arthritis.
Gui H; Liu X; Liu LR; Su DF; Dai SM
Immunobiology; 2015 Jun; 220(6):817-22. PubMed ID: 25601571
[TBL] [Abstract][Full Text] [Related]
18. Local effects of intra-articular injection of anti-rabbit tumor necrosis factor alpha monoclonal antibody in antigen-induced arthritis of the rabbit temporomandibular joint.
Ohtani T; Habu M; Khanal A; Yoshioka I; Matsukawa A; Tominaga K
J Oral Pathol Med; 2012 Jan; 41(1):96-105. PubMed ID: 22004078
[TBL] [Abstract][Full Text] [Related]
19. IL-6 signal blockade ameliorates the enhanced osteoclastogenesis and the associated joint destruction in a novel FcγRIIB-deficient rheumatoid arthritis mouse model.
Ohtsuji M; Lin Q; Nishikawa K; Ohtsuji N; Okazaki H; Tsurui H; Amano H; Shirai T; Nishimoto N; Nishimura H; Hirose S
Mod Rheumatol; 2015 Mar; 25(2):270-7. PubMed ID: 25159156
[TBL] [Abstract][Full Text] [Related]
20. Chimeric anti-IL-17 full-length monoclonal antibody is a novel potential candidate for the treatment of rheumatoid arthritis.
Bai F; Tian H; Niu Z; Liu M; Ren G; Yu Y; Sun T; Li S; Li D
Int J Mol Med; 2014 Mar; 33(3):711-21. PubMed ID: 24378614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
